0.46
-8.51%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ScandiDos
Its shares trade on Nasdaq Stockholm under the ticker SDOS.ST. It has been listed since 11 April 2014. In the fiscal year to 30 April 2026, it reported revenue of SEK 54.2m and a net loss of SEK 3.4m. At that date it held total assets of SEK 66.0m and shareholders' equity of SEK 41.7m.
ScandiDos AB engages in the provision of unique measurement systems and software for dosage and quality assurance within radiation therapy. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-11. The firm's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The firm's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. The company operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 11 Apr 2014
- Employees
- 33
- Website
- scandidos.com ↗
Leadership
Pay as last reported
- Mr. Olof SandenIndependent Chairman of the BoardSEK 250,000
- Mr. Gustaf PiehlChief Executive Officer, since 2020SEK 2.1m
- Ms. Henriette MunchChief Financial Officer
- Mr. Gorgen NilssonChief Technology Officer, Director, since 2002SEK 1.7m
- Mr. Anders AdolfsonMarketing Manager
- Mr. Mikael PalmService Manager
- Mr. Daniel PedersonQuality Manager
- Mr. Peter ReinliSales Manager
- Mr. Jean-Marc BothyDirector
- Mr. Fredric EliassonDirectorSEK 100,000
- Mr. Tom SundelinIndependent DirectorSEK 100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ScandiDos AB has several strengths that contribute to its success in the market. Firstly, the company offers innovative and advanced solutions in the field of quality assurance systems for radiation therapy. Their products are known for their high quality and accuracy, ensuring safe and efficient treatments for patients.
- Secondly, ScandiDos AB has built a strong reputation in the industry, with a track record of delivering reliable and dependable products. This has led to a loyal customer base and long-term relationships with key clients.
- Furthermore, the company benefits from a team of highly skilled professionals who are experts in their respective fields. This expertise allows them to constantly improve their products and stay ahead of competitors.
Weaknesses
- Despite its strengths, ScandiDos AB also faces certain weaknesses that could be potential barriers to its growth. One of the weaknesses is the relatively small size of the company compared to some of its competitors. This may limit their resources and ability to invest in research and development or penetrate new markets.
- Additionally, being a specialized company in the field of radiation therapy quality assurance, ScandiDos AB may face challenges in terms of market saturation. The demand for their products may be limited to specific regions or healthcare facilities, restricting their overall market potential.
Opportunities
- Despite the challenges, ScandiDos AB has identified various opportunities that could drive its future growth. One significant opportunity is the increasing global prevalence of cancer and the growing demand for radiation therapy. This presents a larger market for ScandiDos AB to expand its reach and explore new markets.
- Another opportunity lies in technological advancements within the radiation therapy industry. By staying at the forefront of these developments, ScandiDos AB can continuously innovate its products and maintain a competitive edge in the market.
Threats
- Lastly, ScandiDos AB faces certain threats that could impact its business. Competition from larger, more established corporations with greater financial resources and market presence poses a significant threat. These competitors may have the ability to offer similar products at competitive prices, making it challenging for ScandiDos AB to maintain its market share.
- Furthermore, regulatory changes in the healthcare industry, particularly relating to radiation therapy, can also pose threats in terms of compliance and adapting to new standards. ScandiDos AB needs to stay updated with regulations and ensure its products meet the necessary requirements.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.